Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer

Yao, W; Zhao, X; Gong, Y; Zhang, M; Zhang, L; Wu, Q; Wu, L; Fan, Z; Yan, X; Jiao, S

Jiao, S (corresponding author), Chinese PLA, Med Sch, Beijing, Peoples R China.; Jiao, S (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Yan, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Oncol Dept, 28 Fuxing Rd, Beijing 100853, Peoples R China.

ESMO OPEN, 2021; 6 (2):

Abstract

Background: PD-1/PD-L1 inhibitors in combination with chemotherapy are widely used in clinical practice. However, the ideal combined timing of them ha......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索